Clinical Trials on Relapsing-remitting Multiple Sclerosis
Total 3136 results
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
Neuromed IRCCSUniversity of Rome Tor VergataNot yet recruitingHealthy | Neuromyelitis Optica | Relapsing-Remitting Multiple Sclerosis (RRMS)Italy
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
University of AarhusAarhus University Hospital; Regionshospitalet Viborg, Skive; Gødstrup Hospital; Sorbonne UniversityRecruitingRelapsing Remitting Multiple SclerosisDenmark
-
Contineum TherapeuticsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Hoffmann-La RocheicometrixNot yet recruitingRelapsing Remitting Multiple Sclerosis
-
Nantes University HospitalNot yet recruitingMultiple Sclerosis, Relapsing-remitting
-
University of Southern CaliforniaNovartis PharmaceuticalsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
University of Split, School of MedicineUniversity Hospital of SplitRecruitingMultiple Sclerosis | Relapsing Remitting Multiple SclerosisCroatia
-
Novartis PharmaceuticalsRecruiting
-
Cyprus University of TechnologyThe Cyprus Foundation for Muscular Dystrophy ResearchCompletedMultiple SclerosisCyprus
-
Washington University School of MedicineCompletedRelapsing Remitting Multiple SclerosisUnited States
-
ActelionCompletedMultiple SclerosisPoland, Ukraine, United Kingdom, United States, Germany, Spain, Bulgaria, Romania, Serbia, Canada, Finland, Sweden, Russian Federation, Hungary, Czechia, Netherlands, Israel, Switzerland, Austria, France
-
Providence Health & ServicesCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Jeffrey GelfandActive, not recruitingFecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis (MS-BIOME)Relapsing Remitting Multiple SclerosisUnited States
-
Amsterdam UMC, location VUmcInnovatiefonds Zorgverzekeraars; Stichting MS Research; Stichting TreatmedsEnrolling by invitationRelapsing Remitting Multiple SclerosisNetherlands
-
Johns Hopkins UniversityUniversity of Pennsylvania; Washington University School of Medicine; Yale University and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenAlkermes, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
-
University of VirginiaCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
ActelionCompletedMultiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Hungary, Israel, Italy, Lithuania, Poland, Romania, Russian Federation, South Africa, Ukraine, United Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Estonia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Moldova, Republic of, Montenegro, North Macedonia and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico
-
Rennes University HospitalUnknown
-
Universitätsklinikum Hamburg-EppendorfCompletedRelapsing Remitting Multiple SclerosisGermany
-
Johns Hopkins UniversityUniversity of California, San Francisco; National Multiple Sclerosis SocietyCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
University of Wisconsin, MadisonNational Multiple Sclerosis SocietyCompletedRelapsing Remitting Multiple SclerosisUnited States
-
University of British ColumbiaGenzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisCanada
-
Johns Hopkins UniversityWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
InteKrin Therapeutics, Inc.Completed
-
BayerCompletedMultiple Sclerosis, Relapsing RemittingBelgium, Bosnia and Herzegovina, Italy, Austria, Croatia, Czechia, France, Greece, Hungary, Spain, Switzerland
-
Queen Mary University of LondonMerck Sharp & Dohme LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Synthon BVCompletedMultiple SclerosisUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Germany, Italy, Mexico, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
-
Hoffmann-La RocheHôpital de la Timone; SGS S.A.; STRAGEN ServicesCompletedRelapsing Remitting Multiple SclerosisFrance
-
RedHill Biopharma LimitedCompletedRelapsing Remitting Multiple SclerosisIsrael
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Heinrich-Heine University, DuesseldorfNovartis PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisGermany
-
EMD SeronoTerminatedRelapsing Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisRussian Federation
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden and other collaboratorsCompletedMultiple Sclerosis, Relapsing RemittingGreece
-
Fred LublinNational Institute of Neurological Disorders and Stroke (NINDS)CompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing Remitting Multiple Sclerosis
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
Teva Neuroscience, Inc.Completed
-
Nuron Biotech Inc.UnknownRelapsing Remitting Multiple SclerosisPoland, Spain, Belarus, Bulgaria, Serbia, Ukraine, Russian Federation, Hungary, Italy, Croatia, Georgia, Lebanon
-
BayerCompletedMultiple SclerosisUnited States, Canada